RARA CRAFT DATABASE for FDA Medical Devices
510(k)K242817

FDA DEVICE FACTS

Jason membrane

Botiss Biomaterials GmbH

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEDecember 12, 2025PRODUCT CODENPL

Indications for use

Jason membrane alone or in combination with suitable augmentation materials (like autogenous bone, allogeneic, xenogeneic or alloplastic bone replacement materials) is indicated for immediate or delayed guided tissue and bone regeneration.

- in case of surgical bone defects and bone wall defects

- in the context of sinus floor augmentation and for support of the Schneiderian membrane

- in the context of maxillary ridge augmentation

- in the context of maxillary ridge reconstruction for prosthetic treatment

- in the context of a treatment of fenestration defects

- in case of periodontal bone defects (one to three-wall defects, class I and II furcation defects)

- in case of dehiscence defects

- after apicoectomy, cystectomy, resection of retained teeth and resection of other bone lesions

- in extraction sockets after tooth extractions

- in case of immediate or delayed augmentation around implants in extraction sockets

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 1, 2026